AKT1 and pulmonary fibrosis: Systemic miR-26a KO enhances PTEN expression and suppresses the fibrosis-promoting molecule TIMP-1 by inhibiting the PI3K/Akt-mTOR pathway, thereby attenuating pulmonary fibrosis, as summarized in graphical abstract.